201 related articles for article (PubMed ID: 23266076)
1. The prognostic implications of Hyam's subtype for patients with Kadish stage C esthesioneuroblastoma.
Kaur G; Kane AJ; Sughrue ME; Madden M; Oh MC; Sun MZ; Safaee M; El-Sayed I; Aghi M; McDermott MW; Berger MS; Parsa AT
J Clin Neurosci; 2013 Feb; 20(2):281-6. PubMed ID: 23266076
[TBL] [Abstract][Full Text] [Related]
2. Patient characteristics of olfactory neuroblastoma: experience from a tertiary cancer centre 2000-2016 covering Eastern Denmark.
Gram SB; Grønhøj C; Mann H; Jakobsen KK; Kiss K; Bilde A; von Buchwald C
APMIS; 2018 Aug; 126(8):663-666. PubMed ID: 30168622
[TBL] [Abstract][Full Text] [Related]
3. Esthesioneuroblastoma and sinonasal undifferentiated carcinoma: impact of histological grading and clinical staging on survival and prognosis.
Miyamoto RC; Gleich LL; Biddinger PW; Gluckman JL
Laryngoscope; 2000 Aug; 110(8):1262-5. PubMed ID: 10942123
[TBL] [Abstract][Full Text] [Related]
4. [New system combining Hyams grading system and modified Kadish stage to evaluate the progress of esthesioneuroblastoma].
Lai YY; Lin TJ; Jiang LJ; Deng J; Zuo KJ; Zhang Y; Shi JB
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Jul; 33(7):599-602. PubMed ID: 31327194
[No Abstract] [Full Text] [Related]
5. Esthesioneuroblastoma: the role of adjuvant radiation therapy.
Foote RL; Morita A; Ebersold MJ; Olsen KD; Lewis JE; Quast LM; Ferguson JA; O'Fallon WM
Int J Radiat Oncol Biol Phys; 1993 Nov; 27(4):835-42. PubMed ID: 8244813
[TBL] [Abstract][Full Text] [Related]
6. Retrospective review of adjuvant chemotherapy for esthesioneuroblastoma.
Porter AB; Bernold DM; Giannini C; Foote RL; Link MJ; Olsen KD; Moynihan TJ; Buckner JC
J Neurooncol; 2008 Nov; 90(2):201-4. PubMed ID: 18633576
[TBL] [Abstract][Full Text] [Related]
7. Esthesioneuroblastoma: a Danish demographic study of 40 patients registered between 1978 and 2000.
Theilgaard SA; Buchwald C; Ingeholm P; Kornum Larsen S; Eriksen JG; Sand Hansen H
Acta Otolaryngol; 2003 Apr; 123(3):433-9. PubMed ID: 12737303
[TBL] [Abstract][Full Text] [Related]
8. Advantage of Extended Craniofacial Resection for Advanced Malignant Tumors of the Nasal Cavity and Paranasal Sinuses: Long-Term Outcome and Surgical Management.
Sakata K; Maeda A; Rikimaru H; Ono T; Koga N; Takeshige N; Tokutomi T; Umeno H; Kiyokawa K; Morioka M
World Neurosurg; 2016 May; 89():240-54. PubMed ID: 26875653
[TBL] [Abstract][Full Text] [Related]
9. Radiographic predictors of occult intracranial involvement in olfactory neuroblastoma patients.
Geltzeiler M; Choby GW; Ji KSY; JessMace C; Almeida JP; de Almeida J; Champagne PO; Chan E; Ciporen JN; Chaskes MB; Cornell S; Drozdowski V; Fernandez-Miranda J; Gardner PA; Hwang PH; Kalyvas A; Kong KA; McMillan RA; Nayak JV; Patel C; Patel ZM; Celda MP; Pinheiro-Neto C; Sanusi OR; Snyderman CH; Thorp BD; Van Gompel JJ; Zadeh G; Zenonos G; Zwagerman NT; Wang EW
Int Forum Allergy Rhinol; 2023 Oct; 13(10):1876-1888. PubMed ID: 36841933
[TBL] [Abstract][Full Text] [Related]
10. Esthesioneuroblastoma: case report.
Gondim J; Ramos F; Azevedo J; Carrero FP; Tella OI
Arq Neuropsiquiatr; 2002 Jun; 60(2-A):303-7. PubMed ID: 12068366
[TBL] [Abstract][Full Text] [Related]
11. [Diagnostic difficulties of the patient with sinonasal tract tumor; therapeutic dilemmas - a case report and up to date review].
Majchrzak E; Wegner A; Golusiński W
Otolaryngol Pol; 2011; 65(5):377-82. PubMed ID: 22078289
[TBL] [Abstract][Full Text] [Related]
12. Endoscopic Endonasal Management of Olfactory Neuroblastoma: A Retrospective Analysis of 10 Patients with Quality-of-Life Measures.
Manthuruthil C; Lewis J; McLean C; Batra PS; Barnett SL
World Neurosurg; 2016 Jun; 90():1-5. PubMed ID: 26899467
[TBL] [Abstract][Full Text] [Related]
13. Multidisciplinary treatment of olfactory neuroblastoma: Patterns of failure and management of recurrence.
Petruzzelli GJ; Howell JB; Pederson A; Origitano TC; Byrne RW; Munoz L; Emami B; Clark JI
Am J Otolaryngol; 2015; 36(4):547-53. PubMed ID: 25749259
[TBL] [Abstract][Full Text] [Related]
14. Esthesioneuroblastoma--what is the optimal treatment?
Eriksen JG; Bastholt L; Krogdahl AS; Hansen O; Joergensen KE
Acta Oncol; 2000; 39(2):231-5. PubMed ID: 10859017
[TBL] [Abstract][Full Text] [Related]
15. [Long-term experiences in the therapy of esthesioneuroblastoma].
Koch M; Constantinidis J; Dimmler A; Strauss C; Iro H
Laryngorhinootologie; 2006 Oct; 85(10):723-30. PubMed ID: 16673299
[TBL] [Abstract][Full Text] [Related]
16. Prognostic utility of Hyams histological grading and Kadish-Morita staging systems for esthesioneuroblastoma outcomes.
Bell D; Saade R; Roberts D; Ow TJ; Kupferman M; DeMonte F; Hanna EY
Head Neck Pathol; 2015 Mar; 9(1):51-9. PubMed ID: 24806334
[TBL] [Abstract][Full Text] [Related]
17. Esthesioneuroblastoma: irradiation alone and surgery alone are not enough.
Gruber G; Laedrach K; Baumert B; Caversaccio M; Raveh J; Greiner R
Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):486-91. PubMed ID: 12243826
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of Kadish staging in esthesioneuroblastoma: An analysis of the National Cancer Database.
Konuthula N; Iloreta AM; Miles B; Rhome R; Ozbek U; Genden EM; Posner M; Misiukiewicz K; Govindaraj S; Shrivastava R; Gupta V; Bakst RL
Head Neck; 2017 Oct; 39(10):1962-1968. PubMed ID: 28815831
[TBL] [Abstract][Full Text] [Related]
19. Is sex an independent prognostic factor in esthesioneuroblastoma?
Stokes WA; Camilon PR; Banglawala SM; Nguyen SA; Harvey R; Vandergrift WA; Schlosser RJ
Am J Rhinol Allergy; 2015; 29(5):369-72. PubMed ID: 26358349
[TBL] [Abstract][Full Text] [Related]
20. Comparing Kadish, TNM, and the modified Dulguerov staging systems for esthesioneuroblastoma.
Joshi RR; Husain Q; Roman BR; Cracchiolo J; Yu Y; Tsai J; Kang J; McBride S; Lee NY; Morris L; Ganly I; Tabar V; Cohen MA
J Surg Oncol; 2019 Jan; 119(1):130-142. PubMed ID: 30466166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
